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The superficial femoral popliteal vein (SFPV) has
become well-established as an alternative conduit for
infrainguinal, aortoiliac, and major venous recon-
structions.1-5 Fear that SFPV harvest will result in
significant morbidity because of acute and chronic
venous hypertension persists, and most investigators
report some degree of leg swelling immediately after
harvest.6-9 However, some investigators report har-
vest of the conduit with minimal or no long-term
morbidity, whereas other investigators note signifi-
cant early and late morbidity.6-9 Intuitively, the key
to preventing morbidity appears to be the status of
the veins remaining after the harvest of the SFPV,
particularly the popliteal vein (PV). Therefore, the
length of vein harvested, the presence of venous
competence (of the remaining deep veins after
femoral popliteal vein harvest), and the collateral
vessels between the PV and profunda femoris vein
(PFV) are thought to be important in preventing
significant postharvest morbidity. With these factors
in mind, we performed a cadaver study to deter-
mine: (1) the average lengths of both the superficial
femoral vein (SFV) and the PV; (2) the number and
location of valves in the PV; (3) the number and
location of significant (more than 2 mm in diameter)
collateral veins in the PV; and (4) the average “safe
length” of SFPVs that can be harvested, preserving
at least one valve and one significant collateral vein
Superficial femoral popliteal vein: 
An anatomic study
Steven M. Santilli, MD, PhD, FACS, Eugene S. Lee, MD, Shane E. Wernsing,
BA, Daniel A. Diedrich, BS, Michael A. Kuskowski, PhD, and Ronald L.
Shew, PhD, Minneapolis, Minn
Objective: The superficial femoral popliteal vein (SFPV) has been used as an alternative
conduit for both arterial and venous reconstructive surgery. Its popularity continues to
grow, despite concern about the potential for venous morbidity after harvest. The pur-
pose of this study was to determine an anatomic “safe” length of SFPV for harvest,
assuming that the preservation of at least one valve and one significant collateral vein in
the remaining popliteal vein (PV) segment can minimize venous morbidity.
Methods: Forty-four SFPVs were harvested from 39 cadaveric specimens. The length of
both the superficial femoral vein (SFV) and PV was measured, and the number and loca-
tion of valves and significant side branches (more than 2 mm in diameter) of the PV
were measured. The Student two-tailed t test was used as a means of comparing vein
lengths between the sexes. Correlation coefficients were determined for the effect of
patient height on vein length, stratified by means of sex.
Results: Vein length (SFV mean, 24.4 ± 4 cm; PV mean, 18.8 ± 4 cm) varied with sex
(male SFV mean, 28.1 ± 5 cm; male PV mean, 21.5 ± 3 cm; female SFV mean, 22.6 ±
4 cm; female PV mean, 18.4 ± 3 cm; P = .01). Valve number (mean, 1.8 ± 0.5) and loca-
tion and collateral vein number (mean, 5 ± 1.8) and location were variable and inde-
pendent of height or sex. 
Conclusion: An anatomic “safe” length of SFPV for harvest to minimize venous mor-
bidity would include all the SFV and 12 cm of PV in 95% of women and 15 cm of PV
in 95% of men. We found that the male sex was a significant determinant for a longer
safe length of vein that can be harvested. (J Vasc Surg 2000;31:450-5.)
From the Vascular Surgery Section, Veterans Affairs Medical
Center, Department of Surgery, University of Minnesota (Drs
Santilli and Lee); University of Minnesota Medical School
(Messrs Wernsing and Diedrich); Geriatric Research,
Education, and Clinical Center, Veterans Affairs Medical
Center (Dr Kuskowski); and the Department of Cell Biology
and Neuroanatomy, University of Minnesota (Dr Shew).
Competition of interest: nil.
Supported by a Department of Veterans Affairs Merit Review
Grant and a Public Health Service, National Research Service
Award (1F32HL10076-01). 
Presented at the Fifty-third Annual Meeting of The Society for
Vascular Surgery, Washington, DC, Jun 6–9, 1999.
Reprint requests: Steven M. Santilli, MD, VAMC, 1 Veterans Dr,
Vascular Surgery Section, Surgery 112, Minneapolis, MN
55417.
Copyright © 2000 by The Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/2000/$12.00 + 0 24/1/103972
doi:10.1067/mva.2000.103972
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 3 Santilli et al 451
proximal to the preserved valve in the remaining PV
segment after SFPV harvest.
METHODS
Forty-four SFPVs harvested from 39 cadaveric
specimens were used for data analysis. In five cases, the
SFPVs were harvested bilaterally, whereas the remain-
der were harvested from the right leg. Excluded from
the study were cases with previous leg or knee trauma
(including operative procedures) or SFPV segments
that had been damaged during preservation.
The SFPV was carefully exposed through a
medial leg incision from its junction with the PFV
to the origin of the PV at the entry of the anterior
tibial vein. After exposure, all significant collateral
veins (more than 2 mm, confirmed by means of the
outside diameter measurements) in the PV were
identified, preserved, and photographed (Fig 1).
The location of the collateral veins was measured in
the PV as the distance from the inferior edge of the
adductor hiatus to the collateral vein (Fig 2). SFV
length was measured from the SFV/PFV conflu-
ence to the inferior edge of the adductor hiatus, and
PV length was measured from the inferior edge of
the adductor hiatus to the entry of the anterior tib-
ial vein. 
The SFPV was then opened along its entire length,
the luminal surface was washed with water, and valves
within the PV were identified and photographed (Fig
3). Valve locations in the PV were recorded as dis-
tances from the inferior edge of the adductor hiatus.
The Student two-tailed t test was used as a means
of comparing “anatomic safe vein lengths” between
the sexes, and nonparametric correlation coefficients
were determined to compare the effect of cadaver
height on vein lengths stratified by means of sex
(SPSS 9.0, Chicago, Ill).
RESULTS
Forty-four SFPVs were harvested from 39 cadav-
eric specimens, 13 male (mean height, 170 cm) and
26 female (mean height, 150 cm; Fig 4). All measure-
ments are recorded in Table I. A comparison of right
and left vein lengths was performed by using a paired
two-tailed t test in five cadavers (Table II), and no dif-
ference was found between the two limbs (P = .9).
Both SFV and PV lengths and distances to
valve and collateral branch locations in the PV
Fig 1. Cadaveric dissection of the popliteal vein demonstrating collateral veins (arrows). 
The groin is to the right, and the knee is to the left.
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Table I. Summary of superficial femoral vein and popliteal vein lengths and distances to valves and branches
Average anatomic Anatomic safe
safe length length of PV SFV length PV length PV branch total
Men 50 cm* 15 cm* 28.1 ± 5.0 cm* 21.5 ± 3.0 cm* 5.7 ± 3.0
N = 13, average height, 170 cm
Women 40 cm* 12 cm* 22.6 ± 4.0 cm* 18.4 ± 3.0 cm* 4.6 ± 1.0
N = 26, average height, 150 cm
Total — — 24.4 ± 4.0 cm 18.8 ± 4.0 cm 5.0 ± 1.8
N = 39 cadavers
N = 44 SFPVs
*P < .01 with a two-tailed t test when comparing men with women.
SFV, Superficial femoral vein; PV, popliteal vein; SFPVs, superficial femoral popliteal veins.
Table II. A comparison of right and left popliteal
vein lengths (in centimeters) in five cadavers (P = .9)
Patient Right Left Difference
1 22.1 20.6 1.5
2 24.5 24.0 0.5
3 14.2 15.9 1.7
4 23.1 22.6 0.5
5 18.1 19.5 1.4
were dependent on patient sex and independent of
patient height. SFV and PV lengths were found to
be significantly different between men and women
(P < .01). Men had an average SFV length of 28.1
± 5 cm and a PV length of 21.5 ± 3 cm, whereas
women had an average SFV length of 21.5 ± 3 cm
and a PV length of 18.4 ± 3 cm (Table I).
Nonparametric correlations were performed to
determine the effect of height on vein length. No
significant correlations were found between height
and vein lengths when analyzed by means of sex
(women R, 0.128; P = .53; men R, 0.40; P = .20).
Overall, the average anatomic “safe” vein length of
the SFPV in men is 50 cm, and the average
anatomic “safe” vein length of the SFPV in women
is 40 cm. The anatomic “safe” length of the PV at
a 95% CI level is 15 cm in men and 12 cm in
women (Table I). The 95% CI level is the vein
length at which the longest length can be harvest-
ed in 95% of the population while still leaving one
valve and one collateral branch intact.
DISCUSSION
The SFPV has been used as a conduit for in situ
reconstruction after removal of infected prosthetic
aortic grafts, lower-extremity bypass grafting, and
major venous reconstruction.1-5 Excellent patency
rates for reconstructions with the SFPV are report-
ed,1-5 but a hesitancy about its use remains because
of the potential for significant venous morbidity
after its harvest. Significant variation in venous mor-
bidity, from minimal to debilitating pain and
swelling, after SFPV harvest has been reported.6-9
Further examination of these reports reveals that
there is no accepted standard of care for the length
of vein harvested, preoperative venous evaluation
(including evaluation for valvular competence and
functional venous testing), or standard perioperative
care. Differences in care may account for the varia-
tion in reported morbidity after SFPV harvest, and
therefore, a clinically “safe” length of SFPV for har-
vest has yet to be determined.
Other interventions or pathologic conditions of
the SFPV may shed light on a “safe” length for har-
vest. SFV ligation has been used to prevent pulmonary
emboli from the lower extremity. The procedure fell
into disfavor because of several reasons, including
reports that SFPV ligation causes elevated venous foot
pressures and the demonstration of a high rate venous
ulceration by some investigators.10-12 However,
Masuda et al13 reported a 13-year follow-up study in
which SFV obstruction was demonstrated to be well
tolerated with minimal morbidity, provided the PFV
was patent. These findings suggest that earlier reports
of significant morbidity after SFV ligation may be
attributed to other factors, including incomplete diag-
nosis of the extent of venous disease (either PFV or
proximal vein occlusion). Raju et al14 reported on
obstruction of the SFPV and demonstrated that there
is no correlation between the anatomic locale, the
extent of venous obstruction, or the venographic
occurrence of collaterals and significant venous mor-
bidity. They suggested there was an association
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between venous morbidity and the degree of venous
reflux. These observations suggest that venous mor-
bidity associated with ligation/obstruction of the
SFPV is multifactorial in origin and may be related to
both obstruction and reflux, and that harvest of the
SFV alone without proximal obstruction and with a
patent PFV is free of significant venous morbidity.
We assume that an important factor in reducing
venous morbidity after obstruction is the presence of
significant collateral veins between the PV and the
Distance to first Distance to last
PV branch PV branch PV valve total Distance to first PV valve Distance to last PV valve
3.9 ± 3.0 cm 15.4 ± 4.0 cm 1.8 ± 0.6 5.1 ± 4.0 cm 16.8 ± 3.0 cm
2.7 ± 3.0 cm 13.0 ± 4.0 cm 1.8 ± 0.5 7.4 ± 5.0 cm 13.8 ± 4.0 cm
3.1 ± 3.0 cm 14.0 ± 4.0 cm 1.8 ± 0.5 7.0 ± 5.0 cm 14.1 ± 3.0 cm
Fig 2. Cadaveric dissection of the popliteal artery and popliteal vein as they emerge from the
adductor hiatus. The groin is to the right, and the knee is to the left.
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PFV.15 Mavor and Galloway described the venous
anatomy of the lower extremity, with particular
attention to collateral venous channels.16 They
found that in more than 90% of specimens they
could demonstrate a communication between the
PV or venae comitantes of the popliteal artery and
the common femoral or PFV. The role of collateral
veins in preventing venous morbidity after SFPV
harvest was further supported by Wells et al, who
reported minimal clinical morbidity after SFPV har-
vest.6 In this study, patients were examined with
lower-extremity duplex scanning after SFPV harvest,
and a constant finding was the presence of collateral
veins between the PV stump and the PFV, which the
authors felt were important in the prevention of sig-
nificant venous morbidity. These data suggest that a
patent PV with a collateral network to the PFV or
common femoral vein is important in preventing
venous morbidity after SFPV harvest.
Given the conflicting reports of minimal or signif-
icant venous morbidity and the variety of reporting
methods, it is difficult to determine a “safe” length of
Fig 4. Cadaveric specimen of deep veins of the legs: the common femoral vein, profunda
femoris vein, superficial femoral vein, popliteal vein, and anterior tibial vein.
Fig 3. Close-up of cadaveric dissection of a valve (arrow) in the popliteal vein. The groin is to
the right, and the knee is to the left.
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SFPV for harvest. However, considering these data,
we conclude that venous morbidity associated with
SFPV harvest is probably not dependent on the har-
vest of the SFV, but more likely is caused by the har-
vest of the PV and is associated with two factors: sig-
nificant reflux disease in the veins remaining after
SFPV harvest and the absence of collateral veins from
the PV to the PFV or common femoral vein.
Therefore, we define an anatomic safe length of SFPV
for harvest as a length that would leave one valve in
the distal PV stump (to prevent reflux) and one sig-
nificant collateral vein (more than 2 mm in diameter)
in the PV stump superior to the valve. Although our
study evaluates the anatomic safe vein length, the
basis for which we perform SFV/PV harvest should
be a thorough anatomic study. Clinical correlation
studies are necessary to determine whether these
anatomic safe vein lengths are functionally safe.
Our data were analyzed in relation to height and
sex. Height data were obtained from the medical
records of the patients before death. In examining the
data, we found that the anatomic “safe” vein length
was independent of height and dependent on sex. 
In conclusion, the use of SFPV as an alternative
conduit continues to expand. We have defined an
anatomic “safe” vein length of SFPV for harvest to
include one valve in the distal PV stump (to prevent
reflux) and one significant collateral vein (more than
2 mm in diameter) in the PV stump superior to the
valve. Given these criteria, 15 cm of PV in men and
12 cm of PV in women can be harvested distal to the
inferior edge of the adductor hiatus with a 95% con-
fidence of preserving at least one valve and one col-
lateral vein. In our study, the average anatomic
“safe” length of SFPV for harvest varied from 40 cm
in women to 50 cm in men.
We thank Ms Connie Lindberg for her editorial assis-
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